Method of designing synthetic nucleic acid sequences for optimal protein expression in a host cell
Details for Australian Patent Application No. 2003228440 (hide)
International Classifications
Event Publications
14 August 2003 Complete Application Filed
Priority application(s): 60/369,741 01.04.02 US; 60/379,688 09.05.02 US; 60/425,719 12.11.02 US
27 November 2003 Application Open to Public Inspection
Published as AU-B-2003228440
2 October 2008 Application Accepted
Published as AU-B-2003228440
29 January 2009 Standard Patent Sealed
28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003228441-Recombinant P. falciparum merozoite protein-142 vaccine
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser